Drug Designing and Biomarkers


A biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation along side pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.



Drug designing is an ingenious process to seek out new medication centred on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. this sort of modelling is usually mentioned to as computer-aided drug design.


  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Scoring functions

Related Conference of Drug Designing and Biomarkers

April 03-04, 2023

International Conference on Aging and Gerontology

Rome, Aland Islands
May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France
June 08-09, 2023

10th World Congress on Epigenetics and Chromosome

Valencia, Spain
August 21-22, 2023

6th Annual Conference on Stem Cell and Regenerative Medicine

Frankfurt, Germany
September 25-26, 2023

19th Global Summit on Stem Cell & Regenerative Medicine

Zurich, Switzerland
October 19-20, 2023

5th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
December 07-08, 2023

17th International Conference on Genomics & Pharmacogenomics

San Francisco, USA

Drug Designing and Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in